2002Harbin Yike Daxue xuebaoRequires access

Construction and identification of recombinant plasmid pQE32-HPV18 L1

Gu Hong

Open publisher page 0 citations

Abstract

Objective To construct a recombinant plasmid pQE32 HPV18 L1 for obtaining the HPV18 L1 protein expressed in E.coli and developing the genetically engineered vaccine.Methods PCR was used to amplify the HPV18 L1 gene from plasmid pBR322 HPV18 in which the HPV18 L1 was cloned. A new plasmid, pUC19 HPV18 L1, was then constructed by inserting the amplified HPV18 L1 gene into pUC19, a prokaryotic expression vector.Restriction analysis and sequencing were used to confirm the structure of pUC19 HPV18 L1.A new plasmid, pQE32 HPV18 L1, was then constructed by inserting the amplified HPV18 L1 gene into pQE32 a prokaryotic expression vector.Results A DNA fragment in size of 1.7Kb was amplified. Restriction analysis showed that the amplified gene was inserted into pUC19 correctly. Sequencing showed there was no mutation in both ends of the inserted L1 gene.Conclusion The plasmid pQE32 HPV18 L1 is constructed successfully.

About this research paper

What this paper is about

Objective To construct a recombinant plasmid pQE32 HPV18 L1 for obtaining the HPV18 L1 protein expressed in E.coli and developing the genetically engineered vaccine.Methods PCR was used to amplify the HPV18 L1 gene from plasmid pBR322 HPV18 in which the HPV18 L1 was cloned. A new plasmid, pUC19 HPV18 L1, was then constructed by inserting the amplified HPV18 L1 gene into pUC19, a prokaryotic expression vector.Restriction analysis and sequencing were used to confirm the structure of pUC19 HPV18 L1.A new plasmid, pQE32 HPV18 L1, was then constructed by inserting the amplified HPV18 L1 gene into pQE32 a prokaryotic expression vector.Results A DNA fragment in size of 1.7Kb was amplified. Restriction analysis showed that the amplified gene was inserted into pUC19 correctly. Sequencing showed there was no mutation in both ends of the inserted L1 gene.Conclusion The plasmid pQE32 HPV18 L1 is constructed successfully.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To construct a recombinant plasmid pQE32 HPV18 L1 for obtaining the HPV18 L1 protein expressed in E.coli and developing the genetically engineered vaccine.Methods PCR was used to amplify the HPV18 L1 gene from plasmid pBR322 HPV18 in which the HPV18 L1 was cloned. A new plasmid, pUC19 HPV18 L1, was then constructed by inserting the amplified HPV18 L1 gene into pUC19, a prokaryotic expression vector.Restriction analysis and sequencing were used to confirm the structure of pUC19 HPV18 L1.A new plasmid, pQE32 HPV18 L1, was then constructed by inserting the amplified HPV18 L1 gene into pQE32 a prokaryotic expression vector.Results A DNA fragment in size of 1.7Kb was amplified. Restriction analysis showed that the amplified gene was inserted into pUC19 correctly. Sequencing showed there was no mutation in both ends of the inserted L1 gene.Conclusion The plasmid pQE32 HPV18 L1 is constructed successfully.

Key concepts: pUC19, Plasmid, Recombinant DNA, Gene, Molecular biology, Biology, T-DNA Binary system, Vector (molecular biology)

Related papers

Back to paper searchBrowse research topicsOriginal source
Construction and identification of recombinant plasmid pQE32-HPV18 L1 — Research Paper | ScholarLens